Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery-Reference-Cited by-同舟云学术

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery

Published:2021-04-23 Issue:16 Volume:100 Page:e25599
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Cao Shaobo,He Tao,Xie Jinfeng,Feng Haijun,Liu Kui,Qu Bihui,Wu Xiaoling

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference35 articles.

1. Single-center experience with Lutonix drug-coated balloons in infrapopliteal arteries;Steiner;J Endovasc Ther,2016

2. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Gerhard-Herman;Circulation,2017

3. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease;Herten;Vasc Health Risk Manag,2016

4. The role of drug-coated balloons in in-stent restenosis;Andrassy;J Cardiovasc Surg (Torino),2017

5. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study;Unverdorben;EuroIntervention,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Different Endovascular Treatments of Femoropopliteal Artery In-Stent Restenosis: A Systematic Review and Bayesian Network Meta-Analysis;Annals of Vascular Surgery;2024-07

2. Drug‐coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years;Catheterization and Cardiovascular Interventions;2022-12

3. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis;Journal of Endovascular Therapy;2022-10-03

4. Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis;Computational and Mathematical Methods in Medicine;2022-09-19

5. The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease;Diagnostics;2022-09-12